Clinical trial
Registering the Immune Response to a Flu Vaccination Challenge in PTEN Hamartoma Tumour Syndrome
NCT03630523 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Registering the Immune Response to a Flu Vaccination Challenge in PTEN Hamartoma Tumour Syndrome
- Lead sponsor
- Radboud University Medical Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 2018
- Completion date
- January 31, 2019
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
pten hamartoma tumor syndrome